Inovio to report third quarter 2023 financial results on november 9, 2023

Plymouth meeting, pa. , oct. 26, 2023 /prnewswire/ -- inovio (nasdaq: ino), a biotechnology company focused on developing and commercializing dna medicines to help treat and protect people from hpv-associated diseases, cancer, and infectious diseases, today announced that third quarter 2023 financial results will be released after the market close on november 9, 2023.
INO Ratings Summary
INO Quant Ranking